120 related articles for article (PubMed ID: 21837731)
1. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy.
Cucchetti A; Cescon M; Bigonzi E; Piscaglia F; Golfieri R; Ercolani G; Cristina Morelli M; Ravaioli M; Daniele Pinna A
Liver Transpl; 2011 Nov; 17(11):1344-54. PubMed ID: 21837731
[TBL] [Abstract][Full Text] [Related]
2. Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation.
Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
Am J Transplant; 2019 Aug; 19(8):2210-2218. PubMed ID: 30861298
[TBL] [Abstract][Full Text] [Related]
3. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
Mehta N; Dodge JL; Roberts JP; Yao FY
J Hepatol; 2021 Apr; 74(4):829-837. PubMed ID: 33188904
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm.
Samoylova ML; Dodge JL; Mehta N; Yao FY; Roberts JP
Clin Transplant; 2015 Jan; 29(1):52-9. PubMed ID: 25366656
[TBL] [Abstract][Full Text] [Related]
5. Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis.
Arvind A; Seif El Dahan K; Malhotra R; Daher D; Rich NE; Patel MS; VanWagner LB; Lieber SR; Cotter TG; Louissaint J; Mufti AR; Kulik L; Pillai A; Parikh ND; Singal AG
Liver Transpl; 2024 Jun; 30(6):595-606. PubMed ID: 38466889
[TBL] [Abstract][Full Text] [Related]
6. Optimizing liver transplant prioritization for hepatocellular carcinoma through risk stratification.
Norman J; Mehta N; Kwong A
Curr Opin Organ Transplant; 2023 Aug; 28(4):265-270. PubMed ID: 37339511
[TBL] [Abstract][Full Text] [Related]
7. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.
Clavien PA; Lesurtel M; Bossuyt PM; Gores GJ; Langer B; Perrier A;
Lancet Oncol; 2012 Jan; 13(1):e11-22. PubMed ID: 22047762
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study.
Lamarque C; Segaux L; Bachellier P; Buchard B; Chermak F; Conti F; Decaens T; Dharancy S; Di Martino V; Dumortier J; Francoz-Caudron C; Gugenheim J; Hardwigsen J; Muscari F; Radenne S; Salamé E; Uguen T; Ursic-Bedoya J; Antoine C; Deshayes A; Jacquelinet C; Natella PA; Leroy V; Cherqui D; Oubaya N; Duvoux C
J Hepatol; 2024 Mar; ():. PubMed ID: 38521171
[TBL] [Abstract][Full Text] [Related]
9. Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.
Milana F; Polidoro MA; Famularo S; Lleo A; Boldorini R; Donadon M; Torzilli G
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672457
[TBL] [Abstract][Full Text] [Related]
10. Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation.
Minoux K; Lassailly G; Ningarhari M; Lubret H; El Amrani M; Canva V; Truant S; Mathurin P; Louvet A; Lebuffe G; Goria O; Nguyen-Khac E; Boleslawski E; Dharancy S
Transpl Int; 2022; 35():10569. PubMed ID: 36438781
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future.
Ruch B; Wagler J; Kumm K; Zhang C; Katariya NN; Garcia-Saenz-de-Sicilia M; Giorgakis E; Mathur AK
Curr Oncol; 2022 Oct; 29(10):7537-7551. PubMed ID: 36290870
[TBL] [Abstract][Full Text] [Related]
12. Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
Benkö T; König J; Theysohn JM; Schotten C; Saner FH; Treckmann J; Radunz S
Eur J Med Res; 2022 May; 27(1):74. PubMed ID: 35619164
[TBL] [Abstract][Full Text] [Related]
13. Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors.
Gao Q; Anwar IJ; Abraham N; Barbas AS
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944927
[TBL] [Abstract][Full Text] [Related]
14. Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation.
Pelizzaro F; Gambato M; Gringeri E; Vitale A; Cillo U; Farinati F; Burra P; Russo FP
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638365
[TBL] [Abstract][Full Text] [Related]
15. Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management.
Samant H; Amiri HS; Zibari GB
J Gastrointest Oncol; 2021 Jul; 12(Suppl 2):S361-S373. PubMed ID: 34422400
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of intraoperative radiofrequency ablation for hepatocellular carcinoma and its efficacy as a primary treatment.
Kwon J; Chun KS; Song IS; Kim SH; Han S
Ann Hepatobiliary Pancreat Surg; 2020 Feb; 24(1):24-32. PubMed ID: 32181425
[TBL] [Abstract][Full Text] [Related]
17. Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma.
Wu TH; Wang YC; Cheng CH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
World J Gastrointest Surg; 2020 Jan; 12(1):17-27. PubMed ID: 31984121
[TBL] [Abstract][Full Text] [Related]
18. Unfair Advantages for Hepatocellular Carcinoma Patients Listed for Liver Transplant in Short-Wait Regions Following 2015 Hepatocellular Carcinoma Policy Change.
Brondfield MN; Dodge JL; Hirose R; Heimbach J; Yao FY; Mehta N
Liver Transpl; 2020 May; 26(5):662-672. PubMed ID: 31833634
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma.
Cools KS; Moon AM; Burke LMB; McGinty KA; Strassle PD; Gerber DA
Liver Transpl; 2020 Feb; 26(2):203-214. PubMed ID: 31677319
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Liver Transplant Wait-List Outcomes Among Patients With Hepatocellular Carcinoma With Public vs Private Medical Insurance.
Gutin L; Yao F; Dodge JL; Grab J; Mehta N
JAMA Netw Open; 2019 Aug; 2(8):e1910326. PubMed ID: 31469395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
